BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/3/2014 10:14:00 AM | Browse: 280 | Download: 235
Publication Name World Journal of Gastroenterology
Manuscript ID 6087
Country of Manuscript Source Brazil
Received
2013-10-01 20:42
Peer-Review Started
2013-10-01 21:58
To Make the First Decision
2013-10-14 21:19
Return for Revision
2013-10-15 20:04
Revised
2013-11-12 18:27
Second Decision
2013-11-29 10:56
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-11-29 23:57
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-01-10 16:16
Publish the Manuscript Online
2014-02-17 14:01
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Specialty Gastroenterology and Hepatology
Manuscript Type Topic Highlights
Article Title Percutaneous radiofrequency ablation for early hepatocellular carcinoma: Risk factors for survival
Manuscript Source Invited Manuscript
All Author List Luciana Kikuchi, Marcos Menezes, Aline L Chagas, Claudia M Tani, Regiane SSM Alencar, Marcio A Diniz, Venâncio AF Alves, Luiz Augusto Carneiro D’Albuquerque and Flair José Carrilho
Funding Agency and Grant Number
Funding Agency Grant Number
Alves de Queiroz Family Fund for Research
Corresponding author Luciana Kikuchi, MD, São Paulo Clínicas Liver Cancer Group, Instituto do Câncer do Estado de São Paulo, Hospital das Clínicas, Department of Gastroenterology, University of São Paulo School of Medicine, 255 Arnaldo Avenue, São Paulo 01246000, Brazil. lucianakikuchi@usp.br
Keywords Hepatocellular carcinoma; Radiofrequency ablation; Overall survival; Disease-free survival
Core Tip Radiofrequency ablation (RFA) is widely recognized as an effective therapy for early stage hepatocellular carcinoma (HCC) in patients who are not suitable candidates for surgical resection, such as those with decompensated liver function or portal hypertension. Reports from Brazil of clinical experience with RFA management of HCC are rare. This study evaluated 34 consecutive patients with early HCC treated with RFA at a single Brazilian hospital. RFA was efficacious for promoting local tumor control and positive outcome was related to preserved liver function. Careful evaluation of liver function may help to identify the best candidates for this procedure.
Publish Date 2014-02-17 14:01
Citation Kikuchi L, Menezes M, Chagas AL, Tani CM, Alencar RSSM, Diniz MA, Alves VAF, D’Albuquerque LAC, Carrilho FJ. Percutaneous radiofrequency ablation for early hepatocellular carcinoma: Risk factors for survival. World J Gastroenterol 2014; 20(6): 1585-1593
Url http://www.wjgnet.com/1007-9327/full/v20/i6/1585.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i6.1585
Full Article (PDF) WJG-20-1585.pdf
Full Article (Word) WJG-20-1585.doc
Manuscript File 6087-Review.docx
Answering Reviewers 6087-Answering reviewers.pdf
Copyright License Agreement 6087-Copyright assignment.pdf
Institutional Review Board Approval Form or Document Ethics_Committee_20131001193439.pdf
Non-Native Speakers of English Editing Certificate 6087-Language certificate.pdf
Peer-review Report 6087-Peer review(s).pdf
Scientific Editor Work List 6087-Scientific editor work list.doc